Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Yutopar 50mg/5ml solution for injection ampoules
0701030S0BBABAB
|
Yutopar | Ritodrine hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Zaditen 1mg capsules
0304010AGBBAAAA
|
Zaditen (Systemic) | Ketotifen fumarate | Respiratory System | No data available |
|
Zaedoc 150 tablets
0103010T0BFAAAA
|
Zaedoc | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zalasta 15mg orodispersible tablets
040201060BCAIAU
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 15mg tablets
040201060BCAEAL
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 2.5mg tablets
040201060BCAAAD
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg orodispersible tablets
040201060BCAJAV
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 20mg tablets
040201060BCAFAQ
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 5mg orodispersible tablets
040201060BCAGAS
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 7.5mg tablets
040201060BCACAB
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalcitabine 375microgram tablets
0503010X0AAABAB
|
Zalcitabine | Zalcitabine | Infections | No data available |
|
Zalcitabine 750microgram tablets
0503010X0AAAAAA
|
Zalcitabine | Zalcitabine | Infections | No data available |
|
Zaleplon 10mg capsules
0401010W0AAABAB
|
Zaleplon | Zaleplon | Central Nervous System | No data available |
|
Zaleplon 5mg capsules
0401010W0AAAAAA
|
Zaleplon | Zaleplon | Central Nervous System | No data available |
|
Zalzo 10mg orodispersible tablets
0401010Y0BCABAE
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zalzo 5mg orodispersible tablets
0401010Y0BCAAAD
|
Zalzo | Zolpidem tartrate | Central Nervous System | No data available |
|
Zamadol 100mg/2ml solution for injection ampoules
040702040BDAFAB
|
Zamadol | Tramadol hydrochloride | Central Nervous System | No data available |
|
Zamantos 50mg tablets
0704050Z0BIAAAA
|
Zamantos | Sildenafil (Erectile Dysfunction) | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Zanaflex 2mg tablets
1002020T0BCAAAB
|
Zanaflex | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Zanaflex 4mg tablets
1002020T0BCABAA
|
Zanaflex | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Zanprol 10mg gastro-resistant tablets
0103050P0BEAABC
|
Zanprol | Omeprazole | Gastro-Intestinal System | No data available |
|
Zantac 150mg effervescent tablets
0103010T0BBAFAI
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 150mg/10ml syrup
0103010T0BBAEAE
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 300mg effervescent tablets
0103010T0BBAGAJ
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Zantac 50mg/2ml solution for injection ampoules
0103010T0BBADAD
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.